Current Readings: Sublobar Resection for Non-Small-Cell Lung Cancer

Seminars in Thoracic and Cardiovascular Surgery

Volumn 25, Issue 1, 2013, Pages 22-29

  Donington, Jessica S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenocarcinoma in situ; Minimally invasive adenocarcinoma; Non small cell lung cancer; Sublobar resection

Indexed keywords

CARBON MONOXIDE;

AGE DISTRIBUTION; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER CONTROL; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER REGISTRY; CANCER RISK; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CARCINOMA IN SITU; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FORCED EXPIRATORY VOLUME; HIGH RISK PATIENT; HUMAN; IMAGE ENHANCEMENT; INOPERABLE CANCER; INTERMETHOD COMPARISON; INTRAOPERATIVE RADIOTHERAPY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG HILUS; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG RESECTION; LUNG SEGMENTECTOMY; LUNG SURGERY; LUNG TUMOR; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; MEDICAL SOCIETY; MINIMALLY INVASIVE ADENOCARCINOMA; MOLECULAR BIOLOGY; MONOTHERAPY; OVERALL SURVIVAL; PATIENT CARE; PHASE 2 CLINICAL TRIAL (TOPIC); PREDICTOR VARIABLE; PRIMARY TUMOR; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; RECURRENCE RISK; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SINGLE (MARITAL STATUS); STEREOTACTIC BODY RADIATION THERAPY; SURGICAL RISK; SURVIVAL TIME; THERAPY EFFECT; TREATMENT OUTCOME; TUMOR INVASION; TUMOR VOLUME; WEDGE RESECTION;

CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; HUMANS; LUNG NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT SELECTION; PNEUMONECTOMY; RADIOSURGERY; RISK FACTORS; TREATMENT OUTCOME;

EID: 84879518903     PISSN: 10430679     EISSN: 15329488     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2013.01.005     Document Type: Article

References (33)

1. Crabtree T, Puri V, Timmerman R, et al: Treatment of stage I lung cancer in high-risk and inoperable patients: Comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033). J Thorac Cardiovasc Surg (in press).
2. Fernando H.C., Landreneau R.J., Mandrekar S.J., et al. Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: Results from a multicenter phase III study. J Thorac Cardiovasc Surg 2011, 142:1143-1151.
3. Common Terminology Criteria for Adverse Events (CTCAE), Version 3 2003, US Department of Health and Human Services NIoH, National Cancer Institute.
4. Kates M., Swanson S., Wisnivesky J.P. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer <=1 cm in size: A review of SEER data. Chest 2011, 139:491-496.
5. Koike T., Yamato Y., Yoshiya K., et al. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy. Ann Thorac Surg 2012, 93:1788-1794.
6. Travis W.D., Brambilla E., Noguchi M., et al. International association for the study of lung cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011, 6:244-285.
7. Noguchi M., Morikawa A., Kawasaki M., et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995, 75:2844-2852.
8. Suzuki K., Koike T., Asakawa T., et al. A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol 2011, 6:751-756.
9. Ginsberg R.J., Rubinstein L.V. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995, 60:615-622. discussion 22-23.
10. Lederle F.A. Lobectomy versus limited resection in T1N0 lung cancer. Ann Thorac Surg 1996, 62:1249-1250.
11. Koike T., Yamato Y., Yoshiya K., et al. Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg 2003, 125:924-928.
12. Martin-Ucar A.E., Nakas A., Pilling J.E., et al. A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients. Eur J Cardiothorac Surg 2005, 27:675-679.
13. Okada M., Koike T., Higashiyama M., et al. Radical sublobar resection for small-sized non-small cell lung cancer: A multicenter study. J Thorac Cardiovasc Surg 2006, 132:769-775.
14. Schuchert M.J., Pettiford B.L., Keeley S., et al. Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg 2007, 84:926-932. discussion 32-33.
15. Kilic A., Schuchert M.J., Pettiford B.L., et al. Anatomic segmentectomy for stage I non-small cell lung cancer in the elderly. Ann Thorac Surg 2009, 87:1662-1666. discussion 7-8.
16. Kodama K., Doi O., Higashiyama M., et al. Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: A single-institution study. J Thorac Cardiovasc Surg 1997, 114:347-353.
17. Bando T., Yamagihara K., Ohtake Y., et al. A new method of segmental resection for primary lung cancer: Intermediate results. Eur J Cardiothorac Surg 2002, 21:894-899. discussion 900.
18. Miller D.L., Rowland C.M., Deschamps C., et al. Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. Ann Thorac Surg 2002, 73:1545-1550. discussion 50-51.
19. Schuchert M.J., Kilic A., Pennathur A., et al. Oncologic outcomes after surgical resection of subcentimeter non-small cell lung cancer. Ann Thorac Surg 2011, 91:1681-1687. discussion 7-8.
20. Hamatake D., Yoshida Y., Miyahara S., et al. Surgical outcomes of lung cancer measuring less than 1 cm in diameter. Interact Cardiovasc Thorac Surg 2012, 15:854-858.
21. Yendamuri S, Sharma R, Demmy M, et al: Temporal trends in outcomes following sublobar and lobar resections for small (≤2 cm) non-small cell lung cancers-A surveillance epidemiology end results database analysis. J Surg Res (in press).
22. Shirvani S.M., Jiang J., Chang J.Y., et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys 2012, 84:1060-1070.
23. Fernandez F.G., Crabtree T.D., Liu J., et al. Sublobar resection versus definitive radiation in patients with stage IA non-small cell lung cancer. Ann Thorac Surg 2012, 94:354-360. discussion 60-61.
24. Smith C.B., Swanson S.J., Mhango G., et al. Survival after segmentectomy and wedge resection in stage I non-small-cell lung cancer. J Thorac Oncol 2013, 8:73-78.
25. Kim A.W., Detterbeck F.C., Boffa D.J., et al. Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer. Ann Thorac Surg 2012, 94:895-901.
26. Whitson B.A., Groth S.S., Andrade R.S., et al. Invasive adenocarcinoma with bronchoalveolar features: A population-based evaluation of the extent of resection in bronchoalveolar cell carcinoma. J Thorac Cardiovasc Surg 2012, 143:591-600e1.
27. Whitson B.A., Groth S.S., Andrade R.S., et al. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: A population-based analysis. Ann Thorac Surg 2011, 92:1943-1950.
28. Wisnivesky J.P., Henschke C.I., Swanson S., et al. Limited resection for the treatment of patients with stage IA lung cancer. Ann Surg 2010, 251:550-554.
29. Yendamuri S., Gold D., Jayaprakash V., et al. Is sublobar resection sufficient for carcinoid tumors?. Ann Thorac Surg 2011, 92:1774-1778. discussion 8-9.
30. Rineer J., Schreiber D., Katsoulakis E., et al. Survival following sublobar resection for early-stage non-small cell lung cancer with or without adjuvant external beam radiation therapy: A population-based study. Chest 2010, 137:362-368.
31. Rami-Porta R., Ball D., Crowley J., et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:593-602.
32. Travis W.D., Brambilla E., Noguchi M., et al. International multidisciplinary classification of lung adenocarcinoma: Executive summary. Proc Am Thorac Soc 2011, 8:381-385. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society.
33. Okada M., Nakayama H., Okumura S., et al. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma. J Thorac Cardiovasc Surg 2011, 141:1384-1391.